Trial Profile
A Prospective, Observational Study of Men With Premature Ejaculation Who Are Treated With PRILIGY or Alternate Care.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Oct 2016
Price :
$35
*
At a glance
- Drugs Dapoxetine (Primary)
- Indications Premature ejaculation
- Focus Adverse reactions
- Acronyms PAUSE
- Sponsors Janssen Research & Development
- 15 Apr 2014 Results presented at the 29th Congress of the European Association of Urology.
- 22 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.